Alza Concerta Climbs To 15% Of ADHD Market With 170,000 Patients
Executive Summary
Alza Concerta holds 15% of the attention deficit hyperactive disorder market, Senior VP-Sales & Marketing Dan Swisher told the company's annual analyst meeting in New York City Feb. 27.
You may also be interested in...
Celltech Metadate CD Shows Morning/Afternoon Control Of ADHD, Label Says
Celltech Metadate CD given once daily demonstrates control of attention deficit hyperactivity disorder early and late in the school day, product labeling notes.
Celltech Metadate CD Shows Morning/Afternoon Control Of ADHD, Label Says
Celltech Metadate CD given once daily demonstrates control of attention deficit hyperactivity disorder early and late in the school day, product labeling notes.
Alza Concerta Marketing May Expand ADHD Market, Aid Adderall - Shire CEO
Shire sees preliminary evidence that Alza's marketing of Concerta could expand the ADHD market for Adderall, CEO Rolf Stahel said during an Oct. 31 conference call.